Status | Study |
Enrolling by invitation |
Study Name: Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated Condition: Rift Valley Fever Date: 2009-03-25 Interventions: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine All subjects: 1.0-mL (SQ)doses on day 0, once |
Completed |
Study Name: Cerebral Toxoplasmosis and AIDS Condition: Cerebral Toxoplasmosis AIDS Date: 2008-12-02 Interventions: Other: Toxoplasma PCR assay Toxoplasma PCR assay |
Completed |
Study Name: Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis Condition: Coccidioidomycosis Rheumatoid Arthritis Date: 2008-11-21 |
Completed |
Study Name: A Multi-center Study of Spherule-Derived Coccidioidin Condition: Coccidioidomycosis Date: 2008-06-02 Interventions: Biological: Spherule-derived coccidioidin 1.27 ug of sterile, injectable product (spherule-derived cocci |
Terminated |
Study Name: Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment Condition: Coccidioidomycosis Date: 2008-01-31 Interventions: Drug: nikkomycin Z Stage I: Multiple rising doses. Doses p |
Completed |
Study Name: Safety and Immunogenicity Study of Rift Valley Fever Vaccine Condition: Rift Valley Fever Date: 2007-12-20 Interventions: Biological: RVF Vaccine Part A: Inactivated, Dried (TSI-GSD 200) RVF vaccine will be given as three 1.0- |
Completed |
Study Name: POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) Condition: Coccidioidomycosis Date: 2007-01-17 Interventions: Drug: Posaconazole Posaconazol |
Completed |
Study Name: Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine Condition: Rift Valley Fever Date: 2006-12-21 Interventions: Biological: RVF MP-12 Administer 1 ml SQ |
Completed |
Study Name: Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese Children Condition: Malaria Date: 2006-02-16 Interventions: Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049 3-dose intramuscular |
Completed |
Study Name: Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants Condition: Malaria Date: 2006-02-08 Interventions: Biological: RTS,S/AS02D 3-dose |